Schedule 13G ownership disclosure

Evofem Biosciences Operations, Inc.

Security class unavailable · CUSIP: 30048L104

Event date: 2022-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.2900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-196995
Form type
SC 13G
Filer
Cox Todd Stewart
CIK
CIK 1938465
Filed
Jul 19, 2022
Reporting period
Jun 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub